| 2024-06-13 | ALX Oncology Holdings Inc. ALXO | CHIEF FINANCIAL OFFICER | 12,000 0.0229% | $8.53 | $102,338 | -18.48% | ||
| 2023-12-29 | Sale | ALX Oncology Holdings Inc. ALXO | Chief Financial Officer | 1,893 0.0038% | $15.04 | $28,471 | -5.16% | |
| 2023-06-30 | Sale | ALX Oncology Holdings Inc. ALXO | Chief Financial Officer | 887 0.0021% | $7.34 | $6,511 | +25.37% | |
| 2022-12-29 | Sale | ALX Oncology Holdings Inc. ALXO | Chief Financial Officer | 893 0.0021% | $11.07 | $9,886 | -40.71% | |
| 2021-10-18 | Sale | ALX Oncology Holdings Inc. ALXO | Chief Financial Officer | 7,229 0.0182% | $55.44 | $400,793 | -73.46% | |
| 2021-09-17 | Sale | ALX Oncology Holdings Inc. ALXO | Chief Financial Officer | 11,345 0.0285% | $78.96 | $895,811 | -79.71% | |
| 2021-09-16 | Sale | ALX Oncology Holdings Inc. ALXO | Chief Financial Officer | 1,426 0.0035% | $80.43 | $114,695 | -80.45% | |
| 2021-08-23 | Sale | ALX Oncology Holdings Inc. ALXO | Chief Financial Officer | 60,000 0.1516% | $74.15 | $4.45M | -76.24% | |
| 2021-08-17 | Sale | ALX Oncology Holdings Inc. ALXO | Chief Financial Officer | 10,000 0.0239% | $66.23 | $662,299 | -74.14% | |
| 2020-07-21 | ALX Oncology Holdings Inc. ALXO | Chief Financial Officer | 6,000 0.0062% | $9.50 | $57,000 | +90.48% | ||
| 2012-03-19 | Lineage Cell Therapeutics, Inc. LCTX | Chief Financial Officer | 10,000 0.0199% | $4.68 | $46,757 | -10.81% | ||
| 2011-11-29 | Lineage Cell Therapeutics, Inc. LCTX | Chief Financial Officer | 4,000 0.008% | $4.17 | $16,680 | +3.14% |